Potential target populations and clinical models for testing chemopreventive agents

Urology

Volumn 57, Issue 4 SUPPL. 1, 2001, Pages 171-173

  Klein, Eric A ^a   Meyskens Jr , Frank L ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; DISEASE COURSE; EPIDEMIOLOGY; ETHNOLOGY; HUMAN; MALE; PROSTATE TUMOR; RISK FACTOR; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; CONFOUNDING FACTORS (EPIDEMIOLOGY); DISEASE PROGRESSION; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 0035316214     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-4295(00)00966-3     Document Type: Article

References (11)

1. Zlotta AR, and Schulman CC: Chemoprevention of prostate cancer. Rev Urology 1: 35-40, 1999.
2. Landis SH, Murray T, Bolden S, et al: Cancer statistics 1999. CA Cancer J Clin 49: 8-31, 1999.
3. Smith JR, Freije D, Carpten JD, et al: Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274: 1371-1374, 1995.
4. Carter BS, Bova GS, and Beaty T: Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150: 797-802, 1993.
5. Zlotta AR, and Schulman CC: Clinical evolution of prostatic intraepithelial neoplasia. Eur Urol 35: 498-503, 1999.
6. Eeles RA, Durocher F, Edwards S, et al: Linkage analysis of chromosome 1q markers in 136 prostate cancer families. Am J Hum Genet 62: 653-658, 1998.
7. Jhaveri FM, Zippe CD, Klein EA, et al: Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10 year results. Urology 54: 884-890, 1999.
8. Costantino JP, Gail MH, Pee D, et al: Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91: 1541-1548, 1999.
9. Paris PL, Kupelian PA, Hall J, et al: Association of a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients. Cancer Epidemiol Biomarkers Prev 10: 901-905, 1999.
10. Makridakis NM, Ross RK, Pike MC, et al: Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet 354: 975-978, 1999.
11. Platz EA, Kantoff PW, and Giovannucci E: Epidemiology and risk factors for prostate cancer. In Klein EA (eds): Management of Prostate Cancer. Totowa, NJ, Humana Press. 2000, pp 19-46.